Q-Line Biotech IPO Allotment Chances

Category-wise allotment probability for Q-Line Biotech SME IPO, estimated from live subscription data. Use the dropdown to check another IPO.

Select IPO

Q-Line Biotech IPO

Listed SME

Price Band

Rs 326 - 343

Lot Size

800 shares

Total Subscription

95.30x

Allotment Chances — Q-Line Biotech IPO

Retail 1.6% (71.42x subscribed)

Low chance

S-HNI (2-10L) 1.2% (81.35x subscribed)

Low chance

B-HNI (>10L) 2.8% (178.82x subscribed)

Low chance

If 100 retail investors apply, approximately 2 will get allotment.

Estimated from current subscription data, calibrated against published basis-of-allotment results. Actual allotment depends on the number of applications received and SEBI's allotment rules — draw of lots for Retail, Employee and NII; proportionate for QIB.

Applications Received — Q-Line Biotech IPO

Category	Applications	Subscription	Est. chance	Est. allottees
Retail	1,85,614	71.42x	1.6%	2,963
S-HNI (₹2–10L)	18,618	81.35x	1.2%	229
B-HNI (>₹10L)	31,162	178.82x	2.2%	697
QIB	197	123.94x	Proportionate	—
Total	2,35,591	95.30x	—	—

B-HNI odds for Q-Line Biotech use a correction of 4.00×, derived from this IPO's own lot value (₹2,74,400) rather than a fixed constant. Figures as reported at 5:01 pm, 25 May 2026 IST. QIB is allotted proportionately, so a draw-of-lots chance does not apply to it.

View Full Q-Line Biotech IPO Details

Explore More

Quick links to all IPO sections

▶️ Open IPO Live now ⭐ Best IPO Today Top picks 📅 Upcoming IPO Coming soon 📆 IPO Calendar Dates & schedule ✔️ Closed IPO Allotment pending 📈 Listed IPO Listing gains 🔥 IPO GMP Grey market premium 📊 Subscription Live bidding data 🏆 Allotment Check status 🏢 SME IPO Small & medium 🏦 Mainboard IPO Large cap 💰 Performance Listing returns 📚 Learn IPO guides

How these Q-Line Biotech figures are worked out

Chances start from 1 ÷ subscription times, corrected per category — B-HNI bid above ₹10 lakh but are allotted the same minimum NII lot as an S-HNI, so their real odds run several times better than the raw figure implies. The corrections are measured against published basis-of-allotment documents, not assumed. Read the full method and the measured figures, or see allotment chances for every open IPO.